HemoShear Therapeutics, LLC
Closedhemoshear.com
Charlottesville, United States · Founded 2015 · $44.0M raised
- Headquarters
- Charlottesville, Virginia
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- hemoshear.com
- Total Funding
- $44.0M
- Last Round
- $4.0M Series CJul 2025
- Rounds
- 3
About
HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat rare metabolic disorders, particularly in children with genetic liver defects. Using proprietary tissue-based disease modeling technology, HemoShear recapitulates diseases in vitro to interrogate disrupted biochemical processes and identify drug candidates. The company has collaboration agreements with Pfizer and Horizon Therapeutics.
Summary
HemoShear Therapeutics, LLC is a Biotech company based in Charlottesville, United States, founded in 2015. It has raised $44.0M in total across 3 rounds, most recently a $4.0M Series C round in Jul 2025. Investors include Janus Henderson Investors and Adage Capital.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...